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Abstract.  ZO-1, originally  identified by mAb tech- 
niques,  is the first protein  shown to be specifically as- 
sociated with the tight junction.  Here we describe and 
compare the physical characteristics  of ZO-1  from 
mouse liver and the Madin-Darby  canine  kidney 
(MDCK)  epithelial  cell line.  The  ZO-1  polypeptide 
has an apparent  size of 225 kD in mouse tissues and 
210 kD in canine-derived  MDCK cells as determined 
by SDS-PAGE/immunoblot  analysis.  ZO-1  from both 
sources  is optimally  solubilized  from isolated plasma 
membranes  by either  6  M  urea or high pH conditions; 
partial  solubilization  occurs with 0.3 M  KCI.  The  non- 
ionic detergents,  Triton  X-100 and octyl-13-D-gluco- 
pyranoside,  do not solubilize ZO-1.  These solubility 
properties  indicate that  ZO-1  is a peripherally  as- 
sociated membrane protein.  ZO-1  was purified  to elec- 
trophoretic  homogeneity from  pS]methionine  meta- 
bolically labeled MDCK cells by a combination  of gel 
filtration  and immunoaffinity  chromatography.  Purified 
ZO-1  has an  s2o,w of 5.3 and Stokes radius of 8.6 nm. 
These  values suggest that purified  ZO-1  is an asym- 
metric  monomeric  molecule.  Corresponding  values for 
mouse liver ZO-1, characterized  in impure protein ex- 
tracts,  were 6  s20.w and 9  nm.  ZO-I  was shown to be a 
phosphoprotein  in MDCK cells metabolically  labeled 
with  [3~p]orthophosphate;  analysis of phosphoamino 
acids from purified  ZO-1  revealed only phosphoserine. 
ZO-1  epitope number  was determined  by Scatchard 
analysis of competitive and  saturable binding  of two 
different  ~25I-mAbs to SDS-solubilized  proteins  from 
liver and MDCK cells immobilized  on nitrocellulose. 
Saturation  binding occurs at 26 ng mAb/mg liver and 
63 ng/mg of MDCK cell protein.  This  is equivalent to 
30,000 ZO-1  molecules per MDCK cell assuming  a 
single epitope/ZO-1  molecule. 
T 
HE tight junction is a plasma membrane structure that 
seals together  the  perimeters  of polarized  epithelial 
cell  monolayers  and  provides  the  paracellular  bar- 
rier  necessary  to  maintain  vectoral  secretion,  absorption, 
and transport.  The paracellular conductance, as well as the 
molecular size and charge selectivity established by the junc- 
tion, varies between tissues and evidence has been presented 
that the junction may be under physiologic regulation within 
a single tissue (for reviews see references 6, 23). There is 
also evidence that the tight junction restricts the movement 
of membrane lipids (28) and proteins (22) between the apical 
and basolateral membrane domains, although its role in es- 
tablishing  cell  polarity  is  still  controversial  (2,  30).  It  is 
characteristically  positioned as the apical-most member of 
the lateral  membrane junctional  complex,  which  includes 
adherens  junctions,  desmosomes,  and  gap junctions  (8). 
When viewed by thin section electron microscopy, the tight 
junction  appears  as  a  set  of irregularly  spaced  points  of 
cell-cell membrane apposition.  Freeze-fracture replicas of 
the  tight  junction  reveal  a  band  of variably  spaced  and 
anastomosing  fibrils  that  circumscribe  the cell at the api- 
cal-basolateral  border  (10). These  fibrils  appear  to  cor- 
respond to the points of cell-cell contact and their number 
is proportional to the transepithelial  electrical resistance of 
the epithelium (4,  18). 
An understanding  of the molecular  basis for variability 
and regulation of the tight junction has been impeded by the 
absence of specific biochemical markers.  Our laboratories 
have recently reported, through use of monoclonal antibody 
techniques,  identification  of ZO-1, the first protein uniquely as- 
sociated with the tight junction (25). ZO-1 from mouse tissues 
has an apparent molecular mass of 225 kD on immunoblots 
and is localized, in an uninterrupted manner, along the junc- 
tional complex region. At the ultrastructural  level, using im- 
munogold  labeling,  ZO-1  appears  concentrated  near  the 
cell-cell contact points of the junction. We have now charac- 
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both  mouse  liver  and  the  Madin-Darby  canine  kidney 
(MDCK) cell line. 
Materials and Methods 
Reagents were obtained from Sigma Chemical Co. (St. Louis, MO) unless 
otherwise stated. 
Monoclonal Antibodies 
Detailed methods for production of the mAb, R26.4C,  produced against a 
canalicular-enriched membrane fraction from mouse liver have  been de- 
scribed previously (25).  The present study also uses two additional anti- 
ZO-1 mAbs, R40.40D3 and R40.76, produced by separate but identical fu- 
sion protocols. Because the species source of immunogen in all cases was 
mouse, immunizations were done in rats and fusions performed with the 
mouse myeloma line P3X63  Ag8U.t (CRL  1597; American Type Culture 
Collection, Bethesda, MD). Based on subunit molecular masses ("~56 kD 
and 27 kD) and Stokes radii observed on gel chromatography, all three mAbs 
are of the IgG class. All react specifically with a single 225-kD protein, 
ZO-I, on immunoblots of  mouse tissues and localize exclusively to the junc- 
tional complex region in MDCK cells and mouse tissues by indirect im- 
munofluorescent staining (data not shown). Monoclonal antibodies were 
routinely  collected  from  culture  supernatants  of hybridomas  grown  in 
RPMI-1640  (KC Biologicals Inc., Lenexa, KS) containing Nutridoma-SP 
(Boehringer Mannheim Biochemicals, Indianapolis, IN). Conditioned cul- 
ture media used directly  for staining immunobtots were made 0.2%  in 
NAN3, adjusted to pH 8.0, and stored frozen or at 4~  mAbs were also 
produced by growth of hybridomas in mouse ascites by standard techniques 
(11); however,  a  thymic  mice  (Life  Sciences,  St.  Petersburg,  FL)  were 
used to avoid rejection of the crossed-species (rat-mouse) hybridomas. An- 
tibodies used for production of mAb-immunoaffinity matrix were purified 
from tissue culture supernatants by precipitation with (NH4)2SO4 (40% 
saturated).  The precipitated mAbs were dialyzed against PBS (150 mM 
NaC1, 20 mM NaH2PO+, pH 7.4) and were 90% pure by SDS+PAGE. An- 
tibodies for radiolabeling were further purified to homogeneity by affinity 
chromatography on rabbit anti-rat lgG Sepharose (No.  7613-0081; Cappel 
Laboratories, Cochranville, PA)+ Protein bound in PBS was eluted with 
150 mM NaCI, 0.1 M glycine, pH 3.0, collected, and neutralized in tubes 
containing 200 mM Tris-base, pH  10.0. 
Cell Cultures and Metabolic Labeling 
Hybridomas were maintained as previously described (25),  MDCK cells 
were of the low resistance type I1 strain (3) and were grown on plastic tissue 
culture plates (Lab-Tek Products, Westmont, IL) in DME (KC Biologicals 
Inc.), supplemented with 2 mM glutamine, 10% FBS, and penicillin-strep- 
tomycin. The cells were passaged twice weekly. 
Confluent monolayers were used for all metabolic labeling protocols. For 
32p labeling, cells on 10-cm-diam plates were first depleted of phosphate 
by two 5-rain incubations in 130 mM NaC1, 4.7 mM KC1, 1.2 mM MgCI~, 
1.6 mM CaC12, 5  mM dextrose, 30 mM  Hepes, pH 7.4.  Labeling was 
done in 10 ml/plate of the same buffer supplemented with 40-100 taCi/ml 
of neutralized [32P]orthophosphate  (0.8 mCi/ml; Amersham Corp., Arling- 
ton Heights, IL).  Specific activity of TCA-precipitable whole cell protein 
equilibrated at between 3.5 and 4.5 h at which time cells were used. 3-sS 
labeling was done in cultures depleted of  methionine by two 30-min preincu- 
bations in methionine-free DME (KC Biologicals) supplemented with 10% 
dialyzed FBS. Fresh methionine-free media containing 40-50  taCi/ml  of 
[35S]methionine (>8,000 Ci/mmol; Amersham Corp.) was added for 12-16 h. 
Cells were then washed three times on ice with PBS and processed. 
Tissue Preparation for Z04 Molecular 
Mass Comparison 
CD-I mice were euthanized by cervical dislocation and organs were quickly 
removed and washed in cold PBS.  Liver and kidney tissues were weighed 
and dounced in lO vol (wt/vol) of 1 mM NaHCO3  containing 2 mM phen- 
ylmethylsulfonyl fluoride (PMSF). Stomach and colon mucosal epithelia 
were scraped off of underlying tissue and homogenized in the same manner. 
Protein from all tissues was precipitated with 5% TCA, pelleted by centrifu- 
gation, and solubilized at the same wt/vol ratio in SDS-PAGE sample buffer. 
Proteins  were  subjected  to  electrophoresis  on  7.5%  acrylamide/0.2% 
methylene bisacrylamide gels. Molecular masses were determined from a 
plot of log Mr vs. migration distance by comparison with standards of rab- 
bit skeletal  myosin (200  kD) and the two subunits of human spectrin (as- 
sumed to be 240 and 220 kD). 
Cell Fractionation  and ZO-I Extraction 
Mouse Liver A canalicular-enriched (tight junction-containing) membrane 
fraction from mouse liver was prepared as previously described (24). All 
steps were done on ice or at 4~  After fractionation by sucrose gradient 
centrifugation,  membranes at  the 25:41%  interface were collected and 
diluted with 10 vol of buffer A  (10 mM Tris-HCI, pH 8.0,  1 mM EDTA, 
1 mM dithiothreitol [DTT])  containing the following protease inhibitors: 
2.5 ~tg/ml leupeptin, 0.5 ~tg/ml chymostatin and pepstatin, and 0.02 TIU of 
aprotinin. Membrane samples used for extraction experiments were washed 
twice in buffer A by pelleting at  10,000 g for 20 min, were resuspended in 
9 vol of buffer A containing specific extraction agents (e.g., urea, KCI), and 
membranes were separated from solubilized proteins by centrifugation at 
100,000 g for 1 h. The resultant pellets and supernatants were analyzed by 
SDS-PAGE  and  immunoblotting. Specific extraction conditions are indi- 
cated in Results. 
MDCK  Cells.  Plasma  membrane-enriched fractions from  confluent 
monolayers of MDCK cells were prepared as described previously using 
dounce homogenization to break cells followed by several differential cen- 
trifugation steps (25).  Membranes were washed and extracted by the pro- 
tocol outlined for liver membranes above. 
For  immunoaffinity  purification  of  ZO-1,  membranes  were  further 
purified by sedimentation on a single-step (10:50%)  sucrose gradient spun 
at 100,000 g for 60 min (SW 41  rotor) in 10 mM imidazole, pH 7+4, 1 mM 
EDTA, 0.2 mM PMSE Membranes at the 10:50%  interface were free of 
visible nuclear contamination, as determined by light microscopy. ZO-I was 
extracted from membranes, as indicated in the text, and the insoluble mem- 
brane fraction was removed by sedimentation at  100,000 g for 1 h, Soluble 
protein was fractionated by gel permeation chromatography on S-400 (1.5 
￿  48+0 cm or 2+5 ￿  70.0 cm columns; Pharmacia Fine Chemicals, Piscata- 
way, N  J). ZO-l-containing fractions were located by immunoblot analysis 
of column fractions. 
Immunoaffinity Purification  of  Z04 
Immunoaffinity matrix was prepared by coupling purified R26.4C mAb to 
cyanogen bromide-activated Sepharose (Pharmacia Fine Chemicals) by the 
manufacturer's suggested protocol. Typical  product contained 0.6-0.7 mg of 
mAb/ml of hydrated beads and was stored in PBS, 0.05%  NaN3 at 4~ 
ZO-1 was immunoprecipitated directly from solubilized whole MDCK 
cells  by  the  following protocol.  All  steps  were  carried  out  at  0-4~ 
Confluent monolayers of cells were washed on plates with PBS containing 
0+2 mM PMSE scraped, and collected by centrifugation at 1,000 rpm in a 
clinical centrifuge. ZO-I was extracted from these cells by vortexing in 800 
p.I per plate of extraction buffer (6 M urea, 0.1% Triton X-100 [TX-100], ~ 
10 mM Tris,  pH 8.0,  1 mM DTT+ 5 mM MgCI2,  5 mM EGTA,  150 mM 
NaCI, and 0.2  mM PMSF).  Insoluble material, which contained no im- 
munoreactive 7.+O-1, was removed by centrifugation at 15,000 g for 10 min. 
100 l.tl of supernatant was diluted with 9 vol of extraction buffer without urea 
and 20 I.tl of R26.4C-Sepharose was added and mixed by rotation for 4 h. 
Bound ZO-I  was pelleted in  1.5-ml tubes in an Eppendorf microfuge and 
washed extensively with  150 mM NaCI,  1 M  urea, 0.1% TX-100,  1 mM 
DTT, and  10 mM Tris, pH 8.0. Before SDS-PAGE, beads were washed a 
final time in 10 mM Tris, pH 8.0~ and extracted into an equal vol of 2￿  con- 
centrated SDS-PAGE sample buffer (Ix  is 1% SDS,  I% mercaptoethanol, 
5% glycerol, 5 mM Tris, pH 6.8) with heating to 100~  for 3 rain. ZO-I 
for hydrodynamic studies was purified as above and then removed from the 
beads in 4 vol of buffer containing 150 mM NaCI, 4 M urea,  10 mM Tris, 
pH 7.4,  and  1 mM DTT. 
Hydrodynamic  Characterization 
The sedimentation coefficient, s~0.,,., of ZO-I  was estimated by rate-zonal 
sedimentation on linear 5-20% sucrose gradients in an SW 41  rotor by the 
method of Martin and Ames (19). ZO-1 eluted from the immunoaffinity ma- 
trix was diluted with 4 vol of gradient buffer without sucrose before applica- 
tion to the gradient+ Centrifugation was performed with 400-I.tl samples ap- 
plied to ll.6-ml gradients in 150 mM NaCl, 20 mM Tris, pH 7.4, and l mM 
1. Abbreviation  used in this paper:  TX-IO0, Triton X-100. 
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the positions of marker proteins determined by SDS-PAGE. The position 
of ZO-I was determined by immunoblot analysis; in the case of pure 35S- 
labeled protein, present at a level below detection by immunoblotting, its 
position was determined by scintillation counting of whole gradient frac- 
tions. 
Stokes radius, Ra, was estimated by chromatography of ZO-l-containing 
samples and marker proteins on a Sephacryl S-400 gel filtration column (1.5 
￿  48.0  cm) eluted at 4~  with 8 ml/h of  the same buffer used for sedimenta- 
tion studies (1). Void and included column volumes were determined by the 
positions of Blue Dextran and potassium ferrocyanate, respectively. ZO-I 
was located by immunoblotting or scintillation counting. A plot of Stokes 
radii  of standard proteins vs.  err  -~  (1-Kay) was fit by linear least-squares 
regression and Ra of ZO-1  extrapolated (1). 
Phosphoamino Acid A nalysis 
Confluent cultures of MDCK cells were metabolically labeled for 4 h with 
[32p]orthophosphate  and  ZO-1  collected by  immunoprecipitation as  de- 
scribed above. Immunoprecipitated proteins were subjected to SDS-PAGE. 
ZO-1,  located by autoradiography of dried gels, was cut from the gel and 
rehydrated into 50 mM NH4HCO3.AI1  subsequent procedures for proteo- 
lytic digestion, partial acid hydrolysis, and two-dimensional separation of 
phosphoamino acids on 20  ￿  20-cm cellulose TLC  plates, are those of 
Cooper et al.  (5). 
Quantitative [12q]mAb-binding Studies 
A procedure was established to quantify competitive and saturable binding 
of radiolabeled mAbs to samples of liver and MDCK cells immobilized on 
nitrocellulose paper.  Monoclonal antibodies R40.40D3  and R40.76 were 
purified  to  homogeneity  and  labeled  with  [12SIlBolton Hunter  reagent 
([125I]iodinated p-hydroxyphenylpropionic acid N-hydroxysuccinimide es- 
ter, 2,000 Ci/mmol) by the method suggested by the manufacturer (Amer- 
sham Corp.). Typical specific activities by scintillation counting were ,x,l.5 
x  lO  5 cpm/p.g mAb. Labeled antibodies continued to specifically identify 
ZO-I  on  immunoblots  and  were  stored  in  2  mg/ml  BSA,  PBS,  0.05% 
NAN3. As the antigen source,  livers from 4-6-wk-old female cd-1  mice 
(Charles River Breeding Laboratories, Inc., Willmington, MA) were ho- 
mogenized in 99 vol (wt/vol) of l  mM NaHCO3,  pH 8.0, containing 2.5 
~tg/ml leupeptin, 0.5 p.g/ml chymostatin and pepstatin, and 0.02 TIU aproti- 
nin. Confluent monolayers of MDCK cells were washed three times in cold 
PBS containing 0.2 mM PMSF and scraped into the buffer above.  Protein 
from both sources was quickly precipitated by addition of TCA to 5 %, col- 
lected by centrifugation, and resuspended in 25 mM Tris, pH 8.0, 190 mM 
glycine, 0.1% SDS at a final concentration of 0.5 mg protein/ml. The num- 
ber of MDCK cells and linear intercellular junction length per unit area of 
culture plate were quantified on one half of each of these plates. To make 
these measurements, cells were fixed and permeabilized on the plate in 
100% methanol at  -20~  for 1 min, washed three times for 3  min each 
in PBS, and stained for indirect immunofluorescence microscopy. Cell num- 
ber per unit area was quantified from photomicrographs of  these monolayers 
stained either with antiZO-1  antibodies, which stains exclusively each cell's 
junctional perimeter, or with  rhodamine-conjugated phalloidin (l:100  in 
PBS; Molecular Probes, Inc., Junction City, OR), which stains the zonula 
adherens junctions. Cell perimeter length per unit area of monolayer was 
determined from these micrographs by tracing with an integrating planim- 
eter (Electronic Graphics Calculator;  Numonics Corp.,  Lansdale, PA). 
For quantification of antibody binding, multiple 5-p.g aliquots of TCA- 
precipitated liver or MDCK protein were applied to nitrocellulose paper 
(Schleicher & Schuell Inc., Keene, NH) using a Hybri-slot manifold (0.5 
x  4.0  mm  slot orifice;  Bethesda Research Laboratories,  Gaithersburg, 
MD). Blocking was done in 5% nonfat dry milk (Carnation Co.)/TBS for 
1 h at 37~  Duplicate samples were incubated in known concentrations of 
[~25I]mAbs in  1 mg/ml BSA,  PBS, 0.05%  NAN3, with gentle shaking for 
3 h at room temperature. After removing the blots, free mAb concentration 
was determined by scintillation counting of the incubation solution. Blots 
were washed twice, 4 min each, in large volumes (500 ml) of incubation 
buffer without antibody, and then dried. Antibody binding was quantified 
by integrating the area of densitometry scans on autoradiograms. Standard 
curves of scanned areas vs. [ ~25I]mAb were constructed by directly blotting 
known amounts  of [~25I]mAbs onto  nitrocellulose paper  and  autoradio- 
graphing and scanning them in parallel with unknown samples. Based on 
SDS-PAGE, the molar weight of both mAbs used was 160,400 g/mol (two 
heavy and two light chains); bound antibody protein was converted to bound 
moles of antibody using this conversion. Specific binding was determined 
Figure 1. Comparison of apparent molecular masses of ZO-1 by im- 
munoblot  analysis.  ZO-l-containing  samples  from  the  following 
sources:  lane  1,  mouse liver;  lane 2,  mouse colonic epithelium; 
lane 3, mouse kidney; and lane 4, MDCK cultured cells. Positions 
of molecular mass standards are  indicated. 
as that which was competed by simultaneous incubation in a 50- or 100-fold 
excess of nonradioactive antibody.  Preliminary  studies showed  specific 
binding was only linear up to "~10 I.tg/slot of protein; 5 I.tg/slot was used in 
all reported studies. Specific mAb binding was analyzed by Scatchard plot 
analysis. 
Other Methods 
Methods for SDS-PAGE, electrophoretic transfer of proteins to nitrocellu- 
lose paper, and immunoblot analysis using anti-ZO-I antibodies have been 
described in detail (25)  and are modifications of the methods of Laemmli 
(17) and Towbin et al. (27).  Molecular mass standards for SDS-PAGE were 
human RBC spectrin (240 and 220 kD), skeletal  muscle myosin (200 kD), 
beta-galactosidase (116 kD), phosphorylase (92 kD), BSA (68 kD), and oval- 
bumin (48 kD). Protein determination was done by the method of Hartree 
(13) or the BCA assay (Pierce Chemical Co., Rockford, IL) using a BSA 
standard assuming an OD I~  mg/ml of 6.7 (9).  Autoradiography was done on  280 nm 
Kodak X-OMAT AR film at -70~  using a Lightning Plus-BG intensifying 
screen (DuPont  Co.,  Wilmington,  DE).  Liquid  scintillation counting of 
35S- and  t25I-containing  samples was done in Optifluor (Packard  Instru- 
ments Co.,  Inc.,  Downers Grove, IL).  Standard deviations are presented 
with n, the sample size. Relative ZO-1 content on lanes of  the same immuno- 
blots was determined by scanning densitometry in the reflectance mode. 
Results 
Interspecies  Difference in the Molecular Mass of  ZO-1 
The apparent molecular mass of ZO-1  on  immunoblots is 
225 kD in samples derived from mouse liver and 210 kD in 
the  MDCK  cell  line  (Fig.  1).  This  apparent  interspecies 
difference was seen regardless of whether gel samples were 
taken from whole tissue or from purified membranes, mak- 
ing  proteolysis an  unlikely  explanation  for the  difference. 
This is not an interorgan (i.e., isoform) difference since the 
molecular mass of ZO-1  in  samples derived  from mouse 
liver,  kidney,  colon,  and  stomach were the same (stomach 
data not shown). 
ZO-1 Is a Peripherally-associated  Membrane Protein 
Previous  immunoelectron  microscopic  localization  using 
isolated  liver plasma membranes demonstrated  ZO-1  epi- 
topes on the cytoplasmic surface of the membrane at cell-cell 
membrane contact points (25). These images, however, do not 
resolve whether the antigen is a peripheral or integral mem- 
brane protein. To investigate this we determined the extrac- 
Anderson et al.  Characterization  of the  Tight Junction-specific  Protein,  ZO-I  1143 Figure 2. Extraction characteristics of ZO-1 from purified mouse liver (A and B) and MDCK membranes (C and D). Coomassie-stained 
SDS-PAGE (A and C) and immunoblots of corresponding samples (B and D) showing proteins and ZO-1 in the pellet (P) and supernatant 
(S) after exposure to specified extraction solutions followed by centrifugation at 100,000 g for 1 h. Lanes 1, purified membranes; lanes 
2, exposure to control buffer; lanes 3, pH 11.0; lanes 4, 6 M urea; lanes 5, 0.3 M KCI; lanes 6, 2% TX-100. See Materials and Methods 
for details. Positions of molecular mass standards are indicated. 
tion characteristics of ZO-1 in purified membranes (Fig. 2) 
from both liver (Fig. 2, A and B) and MDCK cells (Fig. 2, 
C and D).  Most effective solubilization of ZO-1  from liver 
membranes occurs under denaturing  conditions  including 
high pH (pH 11) and 6 M urea (Fig. 2 B, lanes 3 and 4). Both 
conditions solubilize a  similar subset of Coomassie-visible 
proteins from the membranes (Fig. 2 A, lanes 3 and 4). Re- 
lease of ZO-1 is almost quantitative with high pH and usually 
80-90% with urea, based on densitometric scans of immu- 
noblots. Addition of 1% TX-100 allowed quantitative solubil- 
ization of ZO-1 with 6 M urea, suggesting 10-20 % may be 
trapped in closed membrane vesicles (results not shown). 
Extraction of hepatocyte membranes with 0.3 M  KCI (Fig. 
2 B, lane 5) released a smaller percent of ZO-1 (never >30 %) 
and frequently promoted extensive proteolysis, despite use 
of numerous protease inhibitors. KC1, NaCI, and KI in con- 
centrations up to 1 M gave similar results. The nonionic de- 
tergents TX-100 (Fig. 2 B, lane 6) or octyl-t3-o-glucopyrano- 
side,  both  at  2%,  which  typically  solubilize  integral 
membrane proteins (29), do not solubilize ZO-1.  These ex- 
traction  characteristics  of ZO-1  from  purified  membrane 
fractions are typical of a peripherally associated protein. Ex- 
traction of ZO-1  from plasma membranes of MDCK cells 
provided qualitatively identical results (Fig. 2, Cand D). Be- 
The Journal of Cell Biology, Volume  106, 1988  1144 Figure 3. Immunoprecipitation  and phosphoamino acid analysis of ZO-1 from [32p]phosphate metabolically labeled MDCK cells. (A) Im- 
munoblot and (B) corresponding autoradiogram. Lanes 1, whole  cell homogenate; lanes 2, protein specifically immunoprecipitated  with 
R26.4C-Sepharose; lanes 3, control precipitate using protein A-Sepharose. Position corresponding to ZO-1 is noted. (C) Autoradiograph 
of [32p]phosphoamino acids contained in immunoprecipitated  ZO-I. First dimension electrophoresis (E); second dimension chromatogra- 
phy (C). Phosphoamino  acid standards were cofractionated, located by ninhydrin staining, and their positions outlined. ZO-1 can be selec- 
tively immunoprecipitated, is a phosphoprotein, and contains only phosphoserine. 
cause nondenaturing extraction conditions proved inefficient 
and frequently, but not invariably,  promoted proteolysis of 
ZO-1 during subsequent attempts at purification, extraction 
in urea was routinely used. 
Phosphoamino Acid Analysis 
ZO-1  is  a  phosphoprotein as demonstrated in  [32P]ortho- 
phosphate metabolically labeled MDCK cells (Fig. 3). SDS- 
PAGE/immunoblot analysis of these cells (Fig. 3 A) demon- 
strates that ZO-1 is present in total soluble protein of MDCK 
cells (lane 1 ), and that ZO-1 can be specifically immunopre- 
cipitated with R26.4C-Sepharose (lane 2). Autoradiographic 
analysis (Fig. 3 B) demonstrates the presence of many phos- 
phoproteins in MDCK cells (lane 1) and that ZO-1, which 
is specifically immunoprecipitated (lane 2), is also phosphor- 
ylated.  When  [32P]ZO-I  was  analyzed for phosphoamino 
acids by two-dimensional electrophoresis and chromatogra- 
phy, only phosphoserine was detected (Fig. 3 C). TCA-pre- 
cipitable  [3ep]phosphate  had  equilibrated  at  the  labeling 
time used and when the phosphoamino acid profile in whole 
MDCK cells was analyzed by identical procedures, the typi- 
cal relative ratios of phosphoserine >  phosphothreonine > 
phosphotyrosine seen in many cell types (5) were detected. 
It should be noted that cells were not subjected to any specific 
stimulus to alter kinase activities. 
Physical Properties of  ZO-1 
We attempted preparative purification of ZO-1 from 100-g 
quantities of mouse liver using a variety of  biochemical tech- 
niques. However, despite the unique fractionation character- 
istics of the  immunoreactive protein  on  sucrose gradient 
centrifugation, gel permeation, ion exchange, and immuno- 
affinity chromatography, the problems of proteolysis and the 
very small amounts of ZO-1 present prevented its purifica- 
tion to homogeneity. We were able to purify analytical quan- 
tities of 35S-labeled ZO-1 from MDCK cells, where proteol- 
ysis is less of a problem, by extracting purified membranes 
followed  by  fractionation  of  solubilized  proteins  on  gel 
permeation and  immunoaffinity chromatography (Fig.  4). 
When proteins are solubilized from purified membranes in 
6 M urea and then fractionated directly by gel chromatogra- 
phy in a buffer without urea, all the immunoreactive ZO-1 
elutes as a single discrete peak. ZO-1 present in these column 
fractions  can  be  quantitatively  immunoprecipitated  with 
R26.4C-Sepharose and then released in a soluble form with 
urea. Immunoaffinity-purified  ZO-1 subjected to SDS-PAGE 
shows a single band of radioactive protein at 210 kD on au- 
toradiograms; no other associated subunits are seen (Fig. 4, 
lane 8). 
Hydrodynamic characterization  of immunoaffinity-puri- 
fled MDCK ZO-I was done by gel permeation chromatogra- 
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Immunoblot showing  ZO-1 in  sequential  steps  of a  purification 
scheme (see Materials  and Methods)  (B) Autoradiogram showing 
proteins  in  corresponding  samples  after  SDS-PAGE.  Lane  1, 
homogenized  MDCK  cells;  lane  2,  low  speed  supernatant  of 
homogenized cells;  lane 3, low speed pellet of homogenized cells; 
lane 4, 6 M urea extract of sucrose gradient-purified membranes; 
lane 5, urea-extracted  membrane pellet; lane 6, peak ZO-l-contain- 
ing fraction from S-400 gel chromatography of urea-extracted  pro- 
teins; lane 7, post-immunoprecipitate  supernatant;  lane 8, ZO-1 im- 
munoprecipitated  from peak S-400 fractions;  lane 9, ZO-1 released 
with urea from immunoaffinity  matrix  and used for hydrodynamic 
characterization  shown  in  Figs.  5  and  6.  Positions  of molecular 
mass  standards  are indicated. 
phy (Fig. 5) and sucrose gradient centrifugation (Fig. 6). The 
elution position of 35S-labeled ZO-1  (Fig.  5) is the same as 
ZO-1 extracted from purified membranes  into either 0.3  M 
KCI (Fig. 5, inset A) or 6 M urea (Fig. 5, inset B), and loaded 
directly  on the  column.  Whether  purified  or in  crude  ex- 
tracts,  immunoreactive ZO-1 behaves with the same mono- 
disperse profile as the pure marker proteins,  implying a sin- 
gle hydrodynamic form.  Because solubilization with salt is 
unlikely to cause denaturation, the similar hydrodynamic be- 
havior  of urea-solubilized  ZO-1  implies  that  the  probable 
denaturation occurring during extraction into urea is revers- 
ible during chromatography in nondenaturing buffers.  The 
sedimentation  of pure  35S-labeled  ZO-1  (Fig.  6)  is also in- 
distinguishable  from ZO-1 extracted in 0.3 M  KC1 (inset A) 
or 6 M urea (inset B). The estimated Stokes radius,  8.6 nm, 
and  s20.w, 5.3,  obtained  by  comparison  with  known  stan- 
dards,  permits calculation of an Mr for the soluble form of 
ZO-1 of 218 kD.  This is  similar to the polypeptide mass of 
210 kD determined  on SDS-PAGE. This  is consistent with 
the  single  polypeptide  visualized  at  210  kD  on  autoradio- 
grams of pure ZO-1 and implies ZO-1, under all conditions 
studied,  behaves  as  a  monomer.  The  calculated  frictional 
coefficient of 2.2 also suggests the structure  is quite asym- 
metric.  All  measurements  of Ra and sz0.w were  repeated  at 
Figure 5.  Estimation  of the Stokes radius of ZO-1 by gel filtration 
chromatography.  35S-labeled ZO-1 was purified by immunoprecip- 
itation and after fractionation  on an S-400 column (1.5 x  48.0 cm) 
located by scintillation counting of whole column fractions.  Elution 
positions  of marker  proteins  are  indicated:  (a)  human  spectrin 
tetramer  (19.4 nm);  (b)  human  spectrin  dimer  (12.3 nm);  (c) 
thyroglobulin (8.5 rim); (d) ferritin (6.1 nm); (e) catalase  (5.2 nm). 
Void volume (Vo) and column-included volume (V,) are indicated. 
(Inset A) Immunoblot of fractions  of ZO-1 chromatographed after 
extraction from membranes with 0.3 M KCI. (Inset  B) Immunoblot 
of fractions  of ZO-1 extracted  in 6 M urea. 
least three times and varied within  "~5 %.  With an error in 
this range, an unidentified subunit of up to 10 kD could con- 
ceivably  be  removed  without  a  detectable  alteration  in 
hydrodynamic properties. 
It was not possible  to make  the  same analytic  measure- 
ments on purified ZO-1 from mouse liver. The physical char- 
acteristics  of immunoreactive ZO-1  could, however, be de- 
termined  in  crude  protein  mixtures.  While  this  does  not 
allow  unambiguous determination  of subunit  composition, 
the results were very similar to those of MDCK ZO-1. Table 
I summarizes the physical characteristics of ZO-1; calculated 
values  are  consistent  with  the  conclusion  that  solubilized 
ZO-1  from both sources  is  an asymmetric monomer. 
Quantification of  ZO-1 Epitopes in Liver 
and MDCK Cells 
It became obvious during attempts to purify ZO-1  that it is 
present at very low levels, as expected from its very limited 
cellular localization.  Because we were not able to purify a 
measurable amount with known yield and thus establish a tis- 
sue  content,  we developed  a  radioimmunoassay  technique 
using ~25I-labeled mAbs to measure the content of ZO-1 epi- 
topes  in  whole  cell  protein  immobilized  on  nitrocellulose 
(see Materials and Methods for details). It was observed that 
radiolabeled  mAbs showed a  saturable binding to immobi- 
lized cell protein which could be competed for by nonlabeled 
antibody.  Representative data for the specific binding of the 
[~25I]R40.76 mAb to immobilized  samples  of whole mouse 
liver and whole MDCK cells is presented in Fig. 7 A (solid 
symbols). The average of  duplicate determinations is plotted. 
Nonspecific binding has been subtracted and in the case of 
MDCK  protein,  was  <5%  of  total  binding.  Nonspecific 
binding to whole liver was usually ~30%  of the total, mak- 
ing measurements in this tissue less reliable than those from 
MDCK cells. There was no specific binding to blotted irrele- 
vant proteins,  such  as  BSA,  or the  protein  constituents  in 
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rate-zonal  sedimentation.  Fractions  presented  top to bottom,  1-18. 
35S-labeled ZO-1 was purified  by immunoprecipitation  (see Fig. 4) 
and after centrifugation,  its  position was  located  by scintillation 
counting of whole gradient  fractions  (e).  (Inset A)  Immunoblot 
profile  of fractions  across  gradient  of proteins  extracted  from 
purified  MDCK plasma membranes into 0.3 M KCI. (Inset B) Im- 
munoblot gradient  profile of proteins obtained  from ZO-l-contain- 
ing fractions of an S-400 column (see  Fig.  5).  Protein applied  to 
the S-400 column had been solubilized  in 6 M urea from purified 
membranes.  Positions  of markers  are  plotted  (o)  vs.  their  Sz0.w 
values and fit by linear least-squares  regression.  Markers are cata- 
lase (11.2), human spectrin (8.4), aldolase (7.3), BSA (4.6), myoglo- 
bin (2.0). Note that ZO-1 whether in crude high salt extracts,  urea- 
solubilized  and fractionated  on S-400, or immunoaffinity-purified 
sediments  with  an s20.w of "~5.3. 
nonfat dry milk.  Scatchard analysis of these data (Fig. 7 B) 
indicates  that  saturation  binding  occurs at 60  ng  mAb/mg 
MDCK cell protein and 26 ng/mg liver protein. The apparent 
binding constants  are  ",,53  nM for MDCK cell and  12 nM 
for mouse liver protein. The average saturation binding mea- 
sured  in four confluent culture  plates  was 63  +  5.7  ng/mg 
and in three  separate  mouse livers  was 32  +  8.0 ng/mg. 
Antibody-binding analysis  to MDCK protein  was dupli- 
cated with a second mAb, R40.40D3 (Fig. 7 A and B, open 
circles). When radiolabeled mAb binding is measured in the 
presence  of 50-fold excess  nonlabeled  mAb the R40.40D3 
Table L Summary of Physical Properties of ZO-1 
from MDCK Cells and Mouse Liver 
Value 
Property  MDCK  ZO-I  Mouse  liver ZO-I 
s2,, w  5.3  6.0 
R,  8.6 nm  9.0 nm 
Mr*  218,000  248,400 
Frictional  ratio (f/fJ*  2.2  2.3 
Mr (SDS electrophoresis)  210,000  225,000 
* Calculated from equations: 
and 
Mr  -  6~xNR~s2... 
R--  8o))  f/f'=  "(3Mr  4rtN  ~'~ 
where v and ~5 were assumed to be those of average soluble proteins, 0.73 cm3/g 
and 0.2  g  of solvent/g of protein (26).  N  =  6.02  ￿  1023. 
A. 
60 
50  O~~-~~O 
lo  p 
0  ...........  i  i  i 
O  40  80  120  160  200 
FREE  (nM) 
B 
12 
E  10 
o  o 
8 
E  6 
4 
h 
~-  2 
O  ,  i  . 
0  10  20  30  40  50  60  70 
BOUND  (ng/mg) 
Figure 7. Binding analysis of the ['25I]R40.76 and ['251]R40.4OD3 
mAbs to mouse  liver  and  MDCK cell  proteins  immobilized  on 
nitrocellulose.  (A) Specific binding of R40.76 to whole mouse liver 
proteins  (A) and  to MDCK cell  proteins  (e);  specific  binding of 
R40.40D3 to MDCK cell proteins  (o). Average of duplicate  deter- 
minations are expressed  as ng of mAb bound per mg of protein vs. 
free antibody concentration.  (B) Scatchard  plot of the binding data 
presented  in A; the same symbols are used.  Saturation  binding oc- 
curs at '~26 ng/mg in liver using the R40.76 mAb and 60 ng/mg in 
MDCK cells for either the mAb. For the R40.76 mAb the apparent 
binding constant  is ~12 nM for mouse liver and 53 nM for MDCK 
cells. 
and R40.76 mAbs demonstrate a mutual lack of competition 
and thus recognize different epitopes.  Saturation binding for 
the R40.40D3 mAb was "~15  % higher (n =  2), or within the 
error of the measurements. 
Although knowledge of the apparent affinities is not neces- 
sary to  establish  epitope  content,  it  is  interesting  that  the 
affinity of the R40.76 antibody for ZO-1  is over four times 
higher in the species originally used as the immunogen. As 
measured by this assay, the binding of R40.76 to ZO-1 in the 
human colonic adenocarcinoma cell line, HT-29, was an or- 
der of magnitude lower in affinity than to mouse ZO-1, possi- 
bly explaining our inability to detect ZO-1 by immunofluo- 
rescent  staining  in these cells  (data  not shown). 
The relationship between ZO-1 epitope content, cell num- 
ber, and junctional perimeter length/cell were defined for the 
MDCK  monolayers by quantifying ZO-1  from one half of 
each  culture  plate  and  staining  the  other  half with  either 
rhodamine-phalloidin or anti-ZO-1 antibodies. This allowed 
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length/cm  2 of monolayer (see Materials and Methods). For 
MDCK type II cells, grown to confluence on plastic, these 
values were 3.1  +  0.6  x  105 cells/cm  ~ of monolayer; 39.4 
+  3.3  I.tg total  cell protein/cm  2 and  13.5 m  of junctional 
length/cm  2.  From these values and the  saturation-binding 
level of the R40.76 mAb there are ,-30,000 ZO-1 epitopes/ 
cell or 690 ZO-1 epitopes/gtm  of junctional perimeter. 
Discussion 
We have presented a description of  the physical and biochem- 
ical characteristics of the tight junction-associated protein 
ZO-1 in mouse liver and in the MDCK cell culture line. 
Aside from the  small  apparent  interspecies  difference in 
polypeptide mass, ZO-1 from both sources appears to be a 
large,  asymmetric, monomeric phosphoprotein tightly as- 
sociated with the junction as a peripheral membrane protein. 
Previous  immunogold labeling  studies (25)  demonstrated 
ZO-1 to be concentrated at the points of cell-cell contact that 
correspond to fibrils observed in freeze-fracture electron mi- 
croscopy. 
ZO-1 solubilized with denaturing concentrations of urea 
showed only limited proteolysis, and its yield was greatly in- 
creased compared with extraction into 0.3  M  KC1. It re- 
gained its native hydrodynamic  characteristics during subse- 
quent gel chromatography in non-urea-containing buffers 
and also after purification to homogeneity by an immuno- 
affinity matrix.  Under  the  solubilization conditions used 
here, we find no evidence for association with nonidentical 
subunits or for ZO-1 oligomerization. However,  it is clear 
that ZO-1 is tightly associated with other membrane compo- 
nents and requires  nonphysiologic conditions for efficient 
solubilization, thus we cannot rule out the possibility that 
ZO-I associates with either itself  or additional subunits in the 
cell. 
ZO-1 is present at low levels. To estimate its cellular con- 
tent, a quantitative radioimmunoassay was developed using 
cell protein immobilized on nitrocellulose. To convert mea- 
surements of mAb binding per cell protein into an estimate 
of the actual number of ZO-1 molecules per cell, several as- 
sumptions must be made. (a) An mAb is bound to every epi- 
tope  at the  measured  saturation binding levels;  (b)  each 
potentially bivalent mAb binds only one epitope; (c) all epi- 
topes are accessible; and (d) there is only one epitope per 
ZO-1 molecule. This last assumption is likely to be correct 
since two different mAbs saturate at the same level. Some of 
these assumptions, however,  are not testable without a pu- 
rified antigen standard. As a synthetic standard we have pro- 
duced and measured mAb binding to a recombinant fl-galac- 
tosidase fusion protein that is recognized by five separate 
anti-ZO-1 mAbs. The cDNA coding for this putative frag- 
ment of ZO-1 was originally identified by screening a rat kid- 
ney-derived cDNA expression library in lambda-gtll with 
the anti-ZO-I antibodies. Two different rabbit polyclonal an- 
tisera to this fusion protein identify only ZO-1 on immuno- 
blots and exclusively stain the junctional complex by im- 
munofluorescence (unpublished results). In the immobilized 
antigen assay, the R40.76 mAb binding saturates at 0.78 mol 
mAb/mol fusion protein, suggesting the other assumptions 
above are approximately correct. 
The measurements presented suggest there are ,'~30,000 
copies of ZO-1 per MDCK cell, or ~700 ZO-1 molecules/ 
~tm of junctional length. This number can be compared to 
the number of fibril particles in published freeze-fracture im- 
ages of MDCK tight junctions. Images produced by Gon- 
zales-Mariscal et al.  (12), where cells were grown under 
identical conditions, demonstrate that fibrils are composed 
of rows of intramembrane particles.  As noted by these au- 
thors, the fibril pattern in cultured MDCK is very irregular, 
varying abruptly between 1 and 10 strands, unlike the regu- 
larity observed in epithelia in situ. However, they determined 
there is an average of four circumferential fibrils and by in- 
spection of their micrographs, which reveal '~120 intramem- 
brane particles/l.tm of fibril length, we derive 480 intramem- 
brane particles/gtm of  junctional length. Thus, the molecules 
of ZO-1, a peripheral protein, and the fibril  particles, per- 
haps representing integral protein component(s) of the junc- 
tion, appear to be present in very similar amounts. 
Although the function of the ZO-1 is unknown, the results 
presented here have helped define some of the possibilities. 
As a  peripheral protein on the cytoplasmic surface of the 
tight junction, it clearly is not an integral membrane protein 
responsible for the freeze-fracture fibrils. However, the close 
apposition of the ZO-1 to points of membrane contact (i.e., 
fibril sites) and the similarity between the number of ZO-1 
molecules and fibril particles certainly suggests that this pro- 
tein  could  interact  directly  with  the  (presumed)  integral 
membrane protein(s) of the fibril. For example, ZO-1 might 
interconnect molecules within a fibril or link fibril molecules 
to cytoskeletal elements of the cytoplasm. It is unlikely, how- 
ever,  that ZO-1 functions to link fibrils together at branch 
sites since it is present in Sertoli cell junctions (25)  where 
fibril-fibril anastamoses are rare.  Alternatively, ZO-1 might 
not bind directly to the fibrils, but rather could be one ele- 
ment of a complex assembly of proteins on the cytoplasmic 
surface of the tight  junction, perhaps analogous to the plaques 
found in association with adherens junctions or desmosomes 
(14, 15). Unlike these junctions, however, the tight junction 
has no extensive plaque structures when viewed by conven- 
tional electron microscopy. 
The observation that ZO-1 is a phosphoprotein raises the 
question of whether this modification has functional signifi- 
cance. One possibility would be that phosphorylation changes 
could modify ZO-1 affinity for another protein in the junction 
complex or modify an unknown enzymatic activity of the 
protein. There exists numerous examples of hormonal agon- 
ists or drugs affecting known kinase systems with coincident 
alteration of tight junction morphology and paracellular per- 
meability (7, 16, 20, 21). However, whether such coincidental 
phenomena are of actual physiologic relevance is  not re- 
solved.  Correlation of ZO-1 phosphorylation levels  with 
functional states of the tight junction may shed light on this 
problem and the physiologically important problem of the 
molecular basis of how tissue-specific tight  junction function 
is generated. 
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